Cookies help us to understand how you use our website so that we can provide you with the best experience when you are on our site. To find out more, read our privacy policy and cookie policy.
Manage Cookies
A cookie is information stored on your computer by a website you visit. Cookies often store your settings for a website, such as your preferred language or location. This allows the site to present you with information customized to fit your needs. As per the GDPR law, companies need to get your explicit approval to collect your data. Some of these cookies are ‘strictly necessary’ to provide the basic functions of the website and can not be turned off, while others if present, have the option of being turned off. Learn more about our Privacy and Cookie policies. These can be managed also from our cookie policy page.
Strictly necessary cookies(always on):
Necessary for enabling core functionality. The website cannot function properly without these cookies. This cannot be turned off. e.g. Sign in, Language
Analytics cookies:
Analytical cookies help us to analyse user behaviour, mainly to see if the users are able to find and act on things that they are looking for. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. Tools used: Google Analytics
Social media cookies:
We use social media cookies from Facebook, Twitter and Google to run Widgets, Embed Videos, Posts, Comments and to fetch profile information.
Consultation on the Potassium Iodide (KI) Pill Working Group's draft report on the Emergency Distribution of Potassium Iodide Within the Ingestion Planning Zone (IPZ) of Pickering Nuclear Generating Station is open from April 6 to July 5, 2021.
In 2019, the CNSC established the KI Pill Working Group to provide clarity on the existing plans and associated responsible authorities to distribute KI pills int he IPZ, in the event of an emergency at the Pickering Nuclear Generating Station.
This draft report was written to meet the mandate of Phase I of the Working Group:
“To fulfill the commitment to the Commission to provide clarity on the existing plans and associated responsible authorities for distributing Potassium Iodide (KI) pills in the ingestion planning zone in the event of an emergency at the Pickering Nuclear Generating Station.”
How to Participate:
The CNSC invites you to comment on the draft report produced by the KI Pill Working Group. The CNSC would also like to hear from you on how well this draft report meets the mandate of Phase I of the Working Group.
The opportunity for reviewers to provide feedback on this draft report is part of the CNSC’s commitment to a transparent consultation process.
Consultation on the Potassium Iodide (KI) Pill Working Group's draft report on the Emergency Distribution of Potassium Iodide Within the Ingestion Planning Zone (IPZ) of Pickering Nuclear Generating Station is open from April 6 to July 5, 2021.
In 2019, the CNSC established the KI Pill Working Group to provide clarity on the existing plans and associated responsible authorities to distribute KI pills int he IPZ, in the event of an emergency at the Pickering Nuclear Generating Station.
This draft report was written to meet the mandate of Phase I of the Working Group:
“To fulfill the commitment to the Commission to provide clarity on the existing plans and associated responsible authorities for distributing Potassium Iodide (KI) pills in the ingestion planning zone in the event of an emergency at the Pickering Nuclear Generating Station.”
How to Participate:
The CNSC invites you to comment on the draft report produced by the KI Pill Working Group. The CNSC would also like to hear from you on how well this draft report meets the mandate of Phase I of the Working Group.
The opportunity for reviewers to provide feedback on this draft report is part of the CNSC’s commitment to a transparent consultation process.
